Skip to content

Achieve Life Sciences ACHV Operating Lease Right-of-Use Assets in Other Assets

Operating Lease Right-of-Use Assets in Other Assets at other companies

Sionna Therapeutics, Inc. Common Stock logo
Sionna Therapeutics, Inc. Common StockSION

Other financials

Income statement

See full
Net income-$10.2M+20.7%
EPS (diluted)-$0.19+48.6%

Balance sheet

See full
Cash & equivalents$28.1M+116%
Total debt$5.6M+332%
Total equity$10.7M+3.9%
Total assets$33.1M+21.0%

Cash flow

See full
Operating cash flow-$6.9M+37.5%
CapEx$750.0
Free cash flow-$12.4M

Valuation

See full
Market cap$585.16M+404%
Enterprise value$562.71M+439%

Returns & leverage

See full
Return on equity-496.1%-906pp
Debt / equity0.5×+0.4×
Current ratio2.6×-0.9×

Where this comes from

Reported directly by Achieve Life Sciences in its filing.

Tagged under the XBRL concept us-gaap:OperatingLeaseRightOfUseAsset.

The official record: Achieve Life Sciences’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about Achieve Life Sciences's operating lease right-of-use assets in other assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Achieve Life Sciences's operating lease right-of-use assets in other assets?
Achieve Life Sciences (ACHV) reported operating lease right-of-use assets in other assets of $49K in Q1 2026.
How has Achieve Life Sciences's operating lease right-of-use assets in other assets changed year-over-year?
Achieve Life Sciences's operating lease right-of-use assets in other assets decreased by 53.8% year-over-year, from $106K to $49K.
What is the long-term trend for Achieve Life Sciences's operating lease right-of-use assets in other assets?
Over 5 years (2020 to 2025), Achieve Life Sciences's operating lease right-of-use assets in other assets has grown at a -15.2% compound annual growth rate (CAGR), from $146K to $64K.